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Peripheral Arterial Disease in the Elderly
The Rotterdam Study
Wouter T. Meijer, Arno W. Hoes, Dominique Rutgers, Michiel L. Bots,
Albert Hofman, Diederick E. Grobbee
Abstract—To assess the age- and sex-specific prevalence of peripheral arterial disease (PAD) and intermittent
claudication (IC) in an elderly population, we performed a population-based study in 7715 subjects (40% men, 60%
women) aged 55 years and over. The presence of PAD and IC was determined by measuring the ankle-arm systolic
blood pressure index (AAI) and by means of the World Health Organization/Rose questionnaire, respectively. PAD
was considered present when the AAI was ,0.90 in either leg. The prevalence of PAD was 19.1% (95% confidence
interval, 18.1% to 20.0%): 16.9% in men and 20.5% in women. Symptoms of IC were reported by 1.6% (95%
confidence interval, 1.3% to 1.9%) of the study population (2.2% in men, 1.2% in women). Of those with PAD, 6.3%
reported symptoms of IC (8.7% in men, 4.9% in women), whereas in 68.9% of those with IC an AAI below 0.90
was found. Subjects with an AAI ,0.90 were more likely to be smokers, to have hypertension, and to have
symptomatic or asymptomatic cardiovascular disease compared with subjects with an AAI of 0.90 or higher. The
authors conclude that the prevalence of PAD in the elderly is high whereas the prevalence of IC is rather low,
although both prevalences clearly increase with advancing age. The vast majority of PAD patients reports no
symptoms of IC. (Arterioscler Thromb Vasc Biol. 1998;18:185-192.)
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Peripheral arterial disease refers to the manifestation ofatherosclerosis in the lower limb distal to the aortic
bifurcation. When PAD becomes symptomatic, patients often
present with complaints of IC: “cramping,” “fatigue,” or
“aching” in the calf of the leg, induced by walking and relieved
by standing still. In '25% of patients with IC, there is a
progression to critical ischemia, eg, rest pain and gangrene, that
may eventually necessitate amputation.1,2
Several studies have demonstrated that patients with
PAD, both with and without symptoms of IC,3–5 are at an
increased risk of cardiovascular morbidity and mortality
compared with subjects without PAD.4,6 –9 In comparison to
the number of reports on other manifestations of athero-
sclerotic disease, however, relatively few population-based
studies on the prevalence of PAD and IC have been
performed. We assessed the prevalence of PAD and IC in a
large population-based study including 7715 subjects aged
55 years and over.
Methods
This study is part of The Rotterdam Study, a prospective follow-up
study designed to investigate determinants of the occurrence and
progression of chronic diseases in the elderly. Emphasis is on four areas
of research: cardiovascular diseases, neurogeriatric diseases, locomotor
diseases, and ophthalmologic diseases. The rationale and design of the
study have been described previously.10
All individuals aged 55 years and over living in a suburb of
Rotterdam, the Netherlands (a total of 10 275 subjects), were
invited to participate in the Rotterdam Study. Baseline measure-
ments were compiled after an extensive interview at the partici-
pant’s home and two visits to the research center. The overall
response rate was 78% (7983 subjects; 3105 men and 4878 women).
Of these, 879 subjects lived in nursing homes.
Intermittent claudication was diagnosed according to the criteria
of the World Health Organization/Rose questionnaire,11 which
was included in the home interview. The prevalence of IC was
assessed in 7715 participants in whom the answers to the Rose-
questionnaire were available.
Blood pressure was calculated as the mean of two consecutive
measurements with a random-zero sphygmomanometer at the right
brachial artery while the patient was in a sitting position. The
presence of PAD was evaluated by measuring the systolic blood
pressure level of the posterior tibial artery at both the left and right
leg using an 8-MHz continuous-wave Doppler probe (Huntleigh
500 D, Huntleigh Technology) and a random-zero sphygmoma-
nometer.12–16 For each leg, a single blood pressure reading was
taken with the subject in the supine position. The ratio of the
systolic blood pressure at the ankle to the systolic blood pressure at
the arm (ie, AAI) was calculated for each leg. The lowest AAI in
either leg was used in the analysis.4 In agreement with the approach
followed by Fowkes et al4 and by Schroll and Munck,17 PAD was
considered present when the AAI was ,0.90 in at least one leg.
The AAI was not determined in 1533 participants: 824 subjects did
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not visit the research center; 4 subjects died before their visit to the
center; and in 705 subjects the systolic arm blood pressure (n57),
the systolic ankle blood pressure (n5559), or both (n5139) were
not measured. The characteristics of these 705 individuals did not
differ appreciably from the population in which the AAI could be
determined. Thus, the AAI was calculated for 6450 participants
(2589 men and 3861 women). We excluded 41 participants (0.6%)
with an AAI.1.50, because this AAI usually reflects arterial
rigidity preventing arterial compression, leading to spuriously high
ankle blood pressure values.
Established cardiovascular risk factors and the presence (or
absence) of symptomatic cardiovascular diseases were recorded, and
several noninvasive measures of atherosclerosis (notably ultrasound
measurements of the carotid arteries and abdominal aorta) were
performed.10
Hypertension was defined as a systolic blood pressure of
160 mm Hg or higher, a diastolic blood pressure of 95 mm Hg or
higher, or current use of antihypertensive drugs for the indication
hypertension.18 Diabetes mellitus was defined as current use of
antidiabetic drugs or a random or postload serum glucose level
.11.0 mmol/L after an oral glucose tolerance test.19,20 Subjects
were categorized in as current smokers, former smokers, or those
who had never smoked. Serum total cholesterol was determined by
an automated enzymatic procedure in a nonfasting blood sample.21
Serum HDL cholesterol was measured after precipitation of the
non-HDL fraction with phosphotungstate-magnesium. Height and
weight were measured and body mass index (kg/m2) was calcu-
lated. A history of myocardial infarction and stroke was obtained
through direct questioning and considered positive when con-
firmed by a physician. A history of angina pectoris was assessed
using the World Health Organization/Rose questionnaire.11 LVH
was assessed using a 12-lead ECG, recorded with an ESAOTE-
ACTA cardiograph with a sampling frequency of 500 Hz and
stored digitally. ECG LVH was determined using an automated
diagnostic classification system, the modular ECG analysis system
(MEANS), based on voltage, shape, and repolarization criteria.22,23
Ultrasonography of both carotid arteries was performed with a
7.5-MHz linear array transducer with a Duplex scanner (ATL
Figure 1. The age- and sex-specific
prevalence of PAD (and 95% CI) accord-
ing to age for men (white bars) and
women (shaded bars).
Selected Abbreviations and Acronyms
AAI 5 ankle-arm systolic blood pressure index
CI 5 confidence interval
ECG 5 electrocardiogram
IC 5 intermittent claudication
LVH 5 left ventricular hypertrophy
PAD 5 peripheral artery disease
WHO 5 World Health Organization
TABLE 1. General Characteristics of 7715 Men and Women
Aged 55 Years or Older in Whom the Presence of PAD and IC
Was Assessed
Characteristic
Men
(n53052)
Women
(n54663)
Age, y, mean (SD) 69.0 (8.7) 71.7 (10.3)
Body mass index, kg/m2, mean (SD) 25.7 (3.7) 26.7 (4.1)
Systolic blood pressure, mm Hg, mean (SD) 139 (22) 140 (23)
Diastolic blood pressure, mm Hg, mean (SD) 75 (12) 73 (12)
Hypertension, % 26.3 33.2
Diabetes mellitus, % 10.0 9.9
Smoking, %
Current 30.4 17.5
Former 61.5 27.1
Serum total cholesterol, mmol/L, mean (SD) 6.30 (1.18) 6.81 (1.22)
Serum HDL cholesterol, mmol/L, mean (SD) 1.22 (0.33) 1.43 (0.37)
Carotid artery*
Intima-media thickness, mm, mean (SD) 0.82 (0.15) 0.78 (0.16)
Plaques (%)
Common carotid 23.3 16.9
Carotid bifurcation 64.2 59.2
History of angina pectoris, % 6.8 6.9
History of myocardial infarction, % 12.2 4.3
History of stroke, % 5.0 4.3
*Data available for the first 1660 participants of the Rotterdam Study.25
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UltraMark IV, Advanced Technology Laboratories) to assess inti-
ma-media thickness of the distal part of the common carotid artery
and the presence of plaques in the common and internal carotid
arteries and carotid bifurcation, as detailed elsewhere.24,25 Common
carotid intima-media thickness was calculated as the mean of the
near and far wall measurements of both left and right carotid
arteries. Ultrasound measurements of the diameter of the abdom-
inal aorta were taken by way of B-mode ultrasound recordings
using a 3.5-MHz linear-array probe (Toshiba SSH 60A, Toshiba
Medical Systems) with the patient in the supine position.26
To compare our prevalence data for PAD and IC with those
reported in other population-based screening surveys, adjusted
prevalences were calculated by applying the age and gender
distributions and definitions of PAD in these other studies to the
Rotterdam Study data set. Prevalence rates were calculated with
exact 95% confidence limits. One-way ANCOVAs were applied to
determine the statistical significance of the differences in cardio-
vascular risk indicators and noninvasive measures of atherosclerosis
between subjects with and without PAD, adjusted for differences
in age between these two groups. All analyses were performed
using BMDP software (BMDP Statistical Software, Inc).
Results
In Table 1, selected characteristics of the study population are
given separately for men and women. PAD was present in
19.1% (95% CI, 18.1% to 20.0%) of all participants. The
prevalence of PAD in women (20.5%; 95% CI, 19.2% to
21.8%) was higher than that in men (16.9%; 95% CI, 15.4% to
18.3%). The age difference between men and women ac-
counted for most of this difference in prevalence, because the
prevalences in 5-year age categories for men and women were
similar. In both men and women, a clear increase in the
prevalence of PAD with age was observed, ranging from 6.6%
in the age category 55 to 59 years to 52.0% in the age category
85 years or over in men, and from 9.5% to 59.6% in the
corresponding age categories in women (Fig 1).
IC was reported by 1.6% (95% CI, 1.3% to 1.9%) of all
participants, whereas the prevalence of IC in men (2.2%;
95% CI, 1.7% to 2.8%) was higher than in women (1.2%;
95% CI, 0.9% to 1.5%). In both men and women, a clear
increase in prevalence of IC with increasing age was present,
ranging from 1.0% in the age category 55 to 59 years to
6.0% in the age category 85 years or over in men, and from
0.7% to 2.5% in the corresponding age categories in women
(Fig 2).
Of the 1166 subjects with PAD, 73 (6.3%) reported
symptoms of IC (Table 2). Interestingly, men with PAD
more often complained of symptoms of intermittent clau-
dication (8.7%) than women with PAD (4.9%). Of the 106
subjects with symptoms of IC according to the Rose
criteria, 73 (68.9%) had PAD, defined as an AAI,0.90. This
proportion was similar in men and women.
The mean AAI was 1.05 (standard deviation [SD], 0.23):
1.08 (SD, 0.24) in men and 1.03 (SD, 0.23) in women. The
AAI decreased sharply with advancing age (Fig 3). The
distribution of AAI values (Fig 4) is skewed to the left. In 41
participants (0.6%), an AAI .1.50 was measured. These 41
participants were not included in the other tables or figures.
Figure 2. The age- and sex-specific
prevalence of IC (and 95% CI) according
to age for men (white bars) and women
(shaded bars).
TABLE 2. PAD and IC in Subjects Aged 55 Years or Older
IC†
PAD*
Present Absent
Total(AAI<0.90) (AAI>0.90)
Men
Present 37 18 55
Absent 387 2117 2504
Women
Present 36 15 51
Absent 706 3008 3714
Total
Present 73 33 106
Absent 1093 5125 6218
*Assessed by measuring the AAI.
†According to the criteria of the WHO/Rose questionnaire.
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In Table 3, subjects with and without PAD are compared
with respect to the presence of cardiovascular risk factors
and disease and noninvasive measures of atherosclerosis.
Subjects with an AAI,0.90 had a more unfavorable car-
diovascular risk profile than did subjects with an AAI$0.90.
In both men and women, hypertension, cigarette smoking,
and a history of stroke were significantly more frequent
among subjects with an AAI,0.90. LVH was more frequent
in those with an AAI,0.90, and similarly, these subjects had
an increased common carotid intima-media thickness, a
higher frequency of carotid plaques, and a larger distal
abdominal aortic diameter.
Tables 4 and 5 show a comparison between the results of
previous large screening surveys assessing the prevalence of
PAD and IC and findings from the Rotterdam Study. When
the definitions for PAD and IC and the population charac-
teristics of these other studies were applied to our own data
set, no major differences in the prevalence estimates were
found.
Discussion
In the population-based Rotterdam Study, the prevalence of
PAD was 19.1%, varying from 6.6% in women aged 55 to 59
years to 59.6% in men aged 85 years or older. Intermittent
Figure 3. AAI (and 95% CI) according to
age for men (white bars) and women
(shaded bars).
Figure 4. The distribution of the AAI for
men (white bars) and women (shaded
bars).
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claudication was reported by 1.6% of the participants, varying
from 0.7% in women aged 55 to 59 years to 6.0% in men aged
85 years or older. Of those with PAD, only 6.3% reported
symptoms of IC. Compared with those with an AAI $0.90,
subjects with an AAI,0.90 clearly had an unfavorable cardio-
vascular risk profile, also with regard to other noninvasive
measures of atherosclerosis.
The response rate in the Rotterdam Study of 78% is
within the range of similar surveys, with response rates
varying from 59% to 98%.3–5,17,27–31 Because of a lower
response rate in the very old in the Rotterdam Study, the
prevalence of PAD and IC may have been underestimated
for this age group, although in a study by Aronow et al32
among 1886 persons with a mean age of 82 years who were
living in a nursing home, the prevalence of PAD was 29%
among men and 23% among women.
We used the AAI at rest as an indicator of PAD. In a
number of surveys, an AAI measurement during exercise or
a reactive hyperemia test was used.16,31,33 Hiatt et al31
concluded that these tests are not as useful as the AAI
measured at rest. By analogy with other studies, we used a
single measurement of the AAI to define PAD. Taking the
mean of consecutive measurements, as for example in the
Limburg PAOD Study,27 would likely have reduced the
prevalence estimates.
There is no consensus regarding the cutoff value for the
AAI to define PAD. Most of the published surveys have
used a cutoff value between 0.80 and 0.95,3–5,17,27,28,30,31
whereas in one, a cutoff value of 0.75 was used.29 Different
cutoff values result in different prevalences for PAD be-
tween the individual surveys, as is clearly illustrated by
comparing the crude and adjusted prevalence rates in
Table 4. Other reasons for reported differences in pre-
valence estimates between published studies are differ-
ences in the age and sex distribution of the screened
populations or the restriction to populations with a higher
risk for PAD (such as dyslipidemic,5 hypertensive,30 or
diabetic31 patients).
TABLE 3. Cardiovascular Risk Indicators in Subjects with an AAI <0.90 or
an AAI >0.90, Adjusted for Differences in Age
Men Women
AAI
P
AAI
P<0.90 >0.90 <0.90 >0.90
Cardiovascular risk factors
Body mass index, kg/m2, mean 25.2 25.8 .43 26.6 26.7 .02
Systolic blood pressure, mm Hg, mean 148 137 .07 150 137 ,.01
Diastolic blood pressure, mm Hg, mean 74 75 .02 74 73 ,.01
IC, %* 9.5 .9 ,.01 5.0 .5 ,.01
Hypertension, %† 39.4 23.8 ,.01 48.1 29.1 ,.01
Serum total cholesterol, mmol/L, mean 6.28 6.32 .60 6.97 6.81 ,.01
Serum HDL cholesterol, mmol/L, mean 1.19 1.21 .06 1.38 1.46 .63
Diabetes mellitus, % 11.9 6.7 .08 16.0 6.3 ,.01
Smoking, %
Current 37.9 21.4 ,.01 21.5 17.1 ,.01
Former 46.7 62.2 ,.01 25.8 29.0 .91
Cardiovascular disease or measures of
atherosclerosis
History of angina pectoris, % 9.3 5.9 .12 9.2 6.4 .24
History of myocardial infarction, % 29.9 17.0 ,.01 15.2 7.4 .34
History of stroke, % 9.0 3.6 ,.01 8.4 2.0 ,.01
Carotid artery‡
Intima-media thickness, mm .880 .804 ,.01 .830 .756 ,.01
Plaques, %
Common carotid 34.4 20.2 ,.01 35.4 10.8 ,.01
Carotid bifurcation 74.2 59.8 .01 66.7 52.3 ,.01
Distal abdominal aortic diameter, mm 23.1 19.3 ,.01 16.8 16.0 ,.01
LVH by ECG, % 17.3 9.5 .05 11.4 4.9 .01
*According to the criteria of the WHO/Rose questionnaire.
†Defined as a systolic blood pressure of 160 mm Hg or higher, or a diastolic blood pressure of
95 mm Hg or higher, or current use of antihypertensive drugs for the indication hypertension.
‡Data available for the first 1660 participants of the Rotterdam Study.25
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Only a minority of the participants with PAD in the Rotter-
dam Study (6.3%) reported symptoms of IC. Other studies
reported figures in the range of 5.3% to 18.9%,3–5,17,27,28,30,31 with
the exception of one study, reporting a prevalence as high as
37.5%.29 This prevalence of 37.5% observed by Coni et al29 should
be interpreted with caution because in this study the strict Rose
criteria were not used to assess the number of subjects with IC.
The relatively low proportion of PAD patients with
complaints of IC can partly be explained by the fact that
many elderly people do not walk far enough to experience
symptoms of IC, because of either impaired vascularization
of the extremities or other typical disorders, such as osteo-
arthritis. Of interest is that women with PAD less often
reported symptoms of IC (4.9%) than men with PAD
(8.7%). Possibly, women more frequently present atypical
symptoms from ischemic disease than men, by analogy with
observations of coronary heart disease.34,35
PAD is often considered an indicator of generalized
atherosclerosis and as such is associated with a poor cardio-
vascular prognosis. This association seems to be true for
participants of this study, as illustrated by the relatively
unfavorable cardiovascular risk profile of those with an AAI
,0.90. From other studies similar findings have been
reported,3,4,6 – 8,27,28 especially for the association between
PAD and hypertension, diabetes mellitus, and smoking. The
finding of an increased common carotid intima-media
thickness, a higher frequency of carotid plaques, and a larger
diameter of the abdominal aorta (as measures of atheroscle-
rosis) supports the relatively poor prognosis of subjects with
an AAI,0.90.
We conclude that the prevalence of PAD in the elderly is
high whereas the prevalence of reported IC is relatively low.
Both prevalences sharply increase with advancing age. The
vast majority of PAD patients reported no symptoms of IC.
This, together with the high prevalence of PAD and
unfavorable cardiovascular risk profile of patients with
PAD, illustrates the need to explore the use of the AAI as a
risk indicator in cardiovascular screening and risk profiling
in medical practice.
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TABLE 4. Prevalence of PAD in Nine Population-Based Screening Surveys and in the
Rotterdam Study
Study Age, y Sex No.
Definition of
AAI
Prevalence
Adjusted
Prevalence,* %% 95% CI
Rotterdam Study $55 Men 2589 ,0.90 16.9 15.4–18.3 16.9
Women 3861 20.5 19.2–21.8 20.5
Stoffers et al27 55–75† Men 1719 ,0.95 11.0 9.5–12.5 16.5
Women 1935 8.6 7.4–9.8 17.0
Newman et al3 $65 Men 2214 ,0.90 13.9 12.5–15.3 22.3
Women 2870 11.4 10.2–12.6 26.5
Vogt et al28 $65 Women 1492 #0.90 5.5 4.3–6.7 26.5
Coni et al29 .65 Men 112 ,0.75 9.1‡ 5.6–12.6 14.0§
Women 153 9.1‡ 14.0§
Fowkes et al4 55–74 Men 809 #0.90 18.3‡ 16.4–20.2 11.6§
Women 783 18.3‡ 11.6§
Newman et al30 $60 Men 82 ,0.90 26.7‡ 20.4–33.0 21.4§
Women 105 26.7‡ 21.4§
Hiatt et al31 44–68 Men 410 ,0.94 11.9‡ 9.8–13.9 13.4§
Women 540 11.9‡ 13.4§
Criqui et al5 38–82 Men 275 #0.80§ 11.7‡ 9.2–14.2 8.7§
Women 338 11.7‡ 8.7§
Schroll/Munck17 60 Men 360 ,0.90 16.0 12.2–19.8 9.7
Women 306 13.0 9.2–16.8 9.2
*The prevalence was adjusted by applying the age and gender distributions and definitions of PAD in the other studies
to the Rotterdam Study data set.
†The age group 45–55 years was not considered in this comparison; the actual studied age group was 45 to 75 years
or over.
‡Prevalence in the total population; no separate estimates according to gender were reported.
§Criqui et al5 used a different approach to assess the prevalence of peripheral arterial disease; the standard AAI was
not used, but 4 different noninvasive measurements of limb perfusion in the lower extremities.
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